Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sleep duration and food intake in people with type 2 diabetes mellitus and factors affecting confectionery intake.
Akiyama T, Yamakawa T, Orime K, Suzuki J, Sakamoto R, Matsuura-Shinoda M, Shigematsu E, Takahashi K, Kaneshiro M, Asakura T, Tanaka S, Kawata T, Yamada Y, Isozaki T, Takahashi A, Osada UN, Kadonosono K, Terauchi Y. Akiyama T, et al. Among authors: terauchi y. J Diabetes Investig. 2023 May;14(5):716-724. doi: 10.1111/jdi.13987. Epub 2023 Feb 6. J Diabetes Investig. 2023. PMID: 36747481 Free PMC article.
Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: A prospective single-center observational study.
Akiyama T, Yamakawa T, Orime K, Ichikawa M, Harada M, Netsu T, Akamatsu R, Nakamura K, Shinoda S, Terauchi Y. Akiyama T, et al. Among authors: terauchi y. J Diabetes Investig. 2024 Feb;15(2):219-226. doi: 10.1111/jdi.14103. Epub 2023 Nov 7. J Diabetes Investig. 2024. PMID: 37934090 Free PMC article.
Endocrinological evaluation of dawn phenomenon in patients with diabetes and comparison of insulin glargine U-100 biosimilar (Insulin Glargine BS Injection "Lilly") and glargine U-300 (Lantus XR): a randomized controlled study.
Hasebe M, Satoh S, Ito K, Tamura H, Terauchi Y. Hasebe M, et al. Among authors: terauchi y. Endocr J. 2023 Aug 28;70(8):777-786. doi: 10.1507/endocrj.EJ22-0562. Epub 2023 May 11. Endocr J. 2023. PMID: 37164694 Free article. Clinical Trial.
Effectiveness of DialBetesPlus, a self-management support system for diabetic kidney disease: Randomized controlled trial.
Waki K, Nara M, Enomoto S, Mieno M, Kanda E, Sankoda A, Kawai Y, Miyake K, Wakui H, Tsurutani Y, Hirawa N, Yamakawa T, Komiya S, Isogawa A, Satoh S, Minami T, Iwamoto T, Takano T, Terauchi Y, Tamura K, Yamauchi T, Nangaku M, Kashihara N, Ohe K. Waki K, et al. Among authors: terauchi y. NPJ Digit Med. 2024 Apr 27;7(1):104. doi: 10.1038/s41746-024-01114-8. NPJ Digit Med. 2024. PMID: 38678094 Free PMC article.
The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.
Kobayashi K, Toyoda M, Hatori N, Tsukamoto S, Kimura M, Sakai H, Furuki T, Chin K, Kanaoka T, Aoyama T, Umezono T, Ito S, Suzuki D, Takeda H, Degawa H, Hishiki T, Shimura H, Nakajima S, Miyauchi M, Yamamoto H, Hatori Y, Hayashi M, Sato K, Miyakawa M, Terauchi Y, Tamura K, Kanamori A. Kobayashi K, et al. Among authors: terauchi y. Cardiovasc Endocrinol Metab. 2023 Sep 28;12(4):e0292. doi: 10.1097/XCE.0000000000000292. eCollection 2023 Dec. Cardiovasc Endocrinol Metab. 2023. PMID: 37779602 Free PMC article.
501 results